Skinvisible, Inc. (SKVI)
OTCMKTS
· Delayed Price · Currency is USD
0.213
+0.013 (6.30%)
At close: Jun 3, 2026
Skinvisible Employees
Skinvisible had 2 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$10,000
Profits / Employee
-$525,107
Market Cap
1.15M
Employees Chart
Skinvisible News
- 10 months ago - Ovation Science and Skinvisible Pharmaceuticals Enhance Their Strategic Partnership in the Obesity Market with Innovative Cannabinoid Delivery Technology with New Developments and Patent Protection - Accesswire
- 1 year ago - Skinvisible Reports Licensee Success in Netherton Syndrome Clinical Studies - Accesswire
- 1 year ago - Skinvisible announces article on transdermal obesity formulation development - TheFly
- 1 year ago - Skinvisible Announces Article Highlighting Its Proprietary Transdermal Obesity Formulation Development - Accesswire
- 2 years ago - Promising Data on Transdermal Obesity Formulations Announced by Skinvisible - Accesswire
- 2 years ago - Skinvisible Inc unveils data on transdermal obesity formulations - TheFly
- 2 years ago - Skinvisible Inc expands obesity patent application for transdermal delivery - TheFly
- 2 years ago - Skinvisible Expands Obesity Patent Application for Transdermal Delivery - Accesswire